According to Sonoma Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$1.52. In 2022 the company made an earnings per share (EPS) of -$2.31 an increase over its 2021 EPS that were of -$2.69.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$1.52 | -34.2% |
2022 | -$2.31 | -14.13% |
2021 | -$2.69 | 118.7% |
2020 | -$1.23 | -60.06% |
2019 | -$3.08 | -84.33% |
2018 | -$19.66 | -21.7% |
2017 | -$25.11 | -241.62% |
2016 | $17.73 | -169.86% |
2015 | -$25.38 | -356.36% |
2014 | $9.90 | -122.01% |
2013 | -$44.98 | -19.37% |
2012 | -$55.79 | -31.88% |
2011 | -$81.90 | -10.34% |
2010 | -$91.35 | -32.56% |
2009 | -$135.45 | -67.18% |
2008 | -$412.65 | -27% |
2007 | -$565.30 | -63.34% |
2006 | -$1,542 | -2.97% |
2005 | -$1,589 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | -$0.27 | -82.24% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | -$1.00 | -34.21% | ๐บ๐ธ USA |